A Framework for Multi-Omic Prediction of Treatment Response to Biologic Therapy for Psoriasis



Foulkes, Amy C, Watson, David S, Carr, Daniel F, Kenny, John G, Slidel, Timothy, Parslew, Richard, Pirmohamed, Munir ORCID: 0000-0002-7534-7266, Anders, Simon, Reynolds, Nick J, Griffiths, Christopher EM
et al (show 2 more authors) (2019) A Framework for Multi-Omic Prediction of Treatment Response to Biologic Therapy for Psoriasis. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 139 (1). pp. 100-107.

[img] Text
nihms-1526519.pdf - Published version

Download (1MB) | Preview

Abstract

Biologic therapies have shown high efficacy in psoriasis, but individual response varies and is poorly understood. To inform biomarker discovery in the Psoriasis Stratification to Optimise Relevant Therapy (i.e., PSORT) study, we evaluated a comprehensive array of omics platforms across three time points and multiple tissues in a pilot investigation of 10 patients with severe psoriasis, treated with the tumor necrosis factor (TNF) inhibitor, etanercept. We used RNA sequencing to analyze mRNA and small RNA transcriptome in blood, lesional and nonlesional skin, and the SOMAscan platform to investigate the serum proteome. Using an integrative systems biology approach, we identified signals of treatment response in genes and pathways associated with TNF signaling, psoriasis pathology, and the major histocompatibility complex region. We found association between clinical response and TNF-regulated genes in blood and skin. Using a combination of differential expression testing, upstream regulator analysis, clustering techniques, and predictive modeling, we show that baseline samples are indicative of patient response to biologic therapies, including signals in blood, which have traditionally been considered unreliable for inference in dermatology. In conclusion, our pilot study provides both an analytical framework and empirical basis to estimate power for larger studies, specifically the ongoing PSORT study, which we show as powered for biomarker discovery and patient stratification.

Item Type: Article
Uncontrolled Keywords: PSORT Consortium, Skin, Humans, Psoriasis, RNA, Messenger, Immunosuppressive Agents, Prognosis, Biological Therapy, Follow-Up Studies, Prospective Studies, Pilot Projects, Gene Expression Regulation, Adult, Female, Male, Etanercept
Depositing User: Symplectic Admin
Date Deposited: 28 Sep 2020 07:37
Last Modified: 18 Jan 2023 23:31
DOI: 10.1016/j.jid.2018.04.041
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3102819